Patent · US Active

Nicked or gapped nucleic acid molecules and uses thereof

US9074205B2 · kind B2 · utility

0Cited by
9References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 18, 2007
Grant dateJul 7, 2015
Priority date
Expiry dateAug 9, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides meroduplex (nicked or gapped) ribonucleic acid molecules (mdRNA) that decreases or silences target gene expression. An mdRNA of this disclosure comprises at least three strands that combine to form at least two non-overlapping double-stranded regions separated by a nick or gap wherein one strand is complementary to a target gene RNA. In addition, the meroduplex may have one or more modifications or substitutions, such as nucleotide base, sugar, terminal cap structure, internucleotide linkage, or any combination of such modifications. Also provided are methods of decreasing expression of a target gene in a cell or in a subject to treat a disease related to altered expression of a target gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.